Gene Liau Stoke Therapeutics, Inc. (STOK) insider trading activity
Gene Liau is EVP Research & Preclinical Dev of Stoke Therapeutics, Inc.. Currently has a direct ownership of 21,351 shares of STOK, which is worth approximately $247,885. The most recent transaction as insider was on Mar 02, 2021, when has been sold 5,195 shares (Common Stock) at a price of $62.99 per share, resulting in proceeds of $327,233. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
21.4K
0%
3M change
0%
12M change
Total Value Held
$247,885
Gene Liau Transaction History
GL
Gene Liau
EVP Research & Preclinical Dev
Bedford, MA